Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
Department of Surgery, State University of New York Health Science Center, Brooklyn 11203.
N
N
Sumrani
J H
JH
Hong
P
P
Daskalakis
T V
TV
Cacciarelli
M S
MS
Markell
B G
BG
Sommer
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005190:Family; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D011446:Prospective Studies; D014019:Tissue Donors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D006680:HLA Antigens; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine